The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On Nov 20, Zacks Investment Research upgraded home health and hospice care provider Abaxis Inc. (ABAX) to a Zacks Rank #2 (Buy). We are impressed with Abaxis' encouraging second-quarter fiscal 2015 ...
UNION CITY, Calif., Oct. 31, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company has signed ...
UNION CITY, Calif., Jan. 22, 2018 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary ...
Abaxis is in the final stages of testing a new software product it calls FUSE, Wood said, which is a web-based package that enables two-way data sharing between its instruments and vet ...
UNION CITY, Calif., June 28, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a company manufacturing point of care instrumentation and consumables for the medical, veterinary, and research markets ...
Looking at the universe of stocks we cover at Dividend Channel, on 8/30/16, Abaxis, Inc. (NASD: ABAX), McKesson Corp. (NYSE: MCK), and Universal Health Services, Inc. (NYSE: UHS) will all trade ...
UNION CITY, Calif., April 30, 2015 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...
Zoetis said it would buy Abaxis, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash. The deal will bolster the Animal health company's position in the fast-growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results